Literature DB >> 27909895

Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient.

Daniela Gavril1, Paul-Louis Woerther2, Aicha Ben Lakhdar2, Linda Mahjoubi3, Emilie Routier3, Elisabeth Chachaty2, Bertrand Gachot4, Stephane De Botton1,5, Jean-Baptiste Micol1, Christophe Willekens6,7.   

Abstract

Scopulariopsis brevicaulis onychomycosis with local cutaneous invasion was diagnosed in an acute leukemia patient and unsuccessfully treated with high-dose micafungin, based on antifungal susceptibility testing. This case should alert clinicians to the possible severe evolution of onychomycosis in neutropenic patients and suggests that surgery should be preferred in such a situation.

Entities:  

Keywords:  Febrile neutropenia; Immunocompromised; Invasive fungal infection; Micafungin; Onychomycosis; Scopulariopsis spp.

Mesh：

Substances：

Year:  2016        PMID： 27909895     DOI： 10.1007/s15010-016-0971-2

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  8 in total

1.  Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea.

Authors:  E Alvarez; D Garcia-Hermoso; D A Sutton; J F Cano; A M Stchigel; D Hoinard; A W Fothergill; M G Rinaldi; F Dromer; J Guarro
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

Review 2.  Other fungi causing onychomycosis.

Authors:  Gabriela Moreno; Roberto Arenas
Journal:  Clin Dermatol       Date:  2010-03-04       Impact factor: 3.541

3.  In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.

Authors:  Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Maria J Buitrago; Emilia Mellado; Guillermo Garcia-Effron; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.

Authors:  Magdalena Skóra; Małgorzata Bulanda; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

5.  [Antifungal susceptibility of clinical isolates of Scopulariopsis species].

Authors:  V Odero; L García-Agudo; I Guerrero; P Aznar; P García-Martos; M Rodríguez-Iglesias
Journal:  Rev Esp Quimioter       Date:  2014-03       Impact factor: 1.553

Review 6.  Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species.

Authors:  Peter C Iwen; Stephanie D Schutte; Diana F Florescu; Rhonda K Noel-Hurst; Lynne Sigler
Journal:  Med Mycol       Date:  2012-04-23       Impact factor: 4.076

7.  Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa.

Authors:  Dea Garcia-Hermoso; Damien Hoinard; Jean-Charles Gantier; Frédéric Grenouillet; Françoise Dromer; Eric Dannaoui
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

8.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

Authors:  A M Tortorano; M Richardson; E Roilides; A van Diepeningen; M Caira; P Munoz; E Johnson; J Meletiadis; Z-D Pana; M Lackner; P Verweij; T Freiberger; O A Cornely; S Arikan-Akdagli; E Dannaoui; A H Groll; K Lagrou; A Chakrabarti; F Lanternier; L Pagano; A Skiada; M Akova; M C Arendrup; T Boekhout; A Chowdhary; M Cuenca-Estrella; J Guinea; J Guarro; S de Hoog; W Hope; S Kathuria; O Lortholary; J F Meis; A J Ullmann; G Petrikkos; C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2014-04       Impact factor: 8.067
  8 in total
  1 in total

1.  Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia.

Authors:  Keiji Kurata; Sho Nishimura; Hiroya Ichikawa; Rina Sakai; Yu Mizutani; Kei Takenaka; Seiji Kakiuchi; Yoshiharu Miyata; Akihito Kitao; Kimikazu Yakushijin; Shinichiro Kawamoto; Katsuya Yamamoto; Mitsuhiro Ito; Hiroshi Matsuoka; Issei Tokimatsu; Katsuhiko Kamei; Hironobu Minami
Journal:  Int J Hematol       Date:  2018-07-09       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.